Clinical course of chronic heart failure with preserved ejection fraction after radiofrequency catheter ablation for atrial fibrillation
Abstract
Introducrion. Recent randomized controlled trials suggest that catheter ablation of atrial fibrillation (AF) in heart failure (HF) patients leads to improvements in left ventricular function, exercise capacity, and quality of life, but focused on HF with reduced left ventricle ejection fraction (LVEF). Aim. To study the clinical course of chronic heart failure with preserved ejection fraction after radiofrequency catheter ablation for atrial fibrillation. Materials and methods. 194 patients with AF and chronic HF with preserved ejection fraction were included in the study: 136 patients – underwent catheter ablation (CA) for AF; 58 − control group, who continued pharmacological therapy (PT) for rhythm control strategy. All the patients had New York Heart Association (NYHA) class I, II or III HF, LVEF > 40 %. Baseline characteristics comprised demographic and clinical data, medical history echocardiography and ECG results of the included patients. Results. Patients on PT were significantly more symptomatic for HF in comparison to CA patients (the average value of NYHA class HF 2,2 ± 07 versus (vs.) 1,8 ± 0,6; p = 0,019), but AF for itself were more symptomatic in CA group (the average value of EHRA 3,1 ± 0,5 vs. 2,9 ± 0,6; p = 0,001). Among patients with HF with preserved LVEF who underwent CA and were followed-up 24 months 52,9 % of patients remained free of AF recurrence; while in the control group only 7 %. At the 24 months follow-up NYHA class significantly improved in ablation group, as well as EHRA score. Conclusions. Radiofrequency catheter ablation was associated with improved the clinical course of chronic heart failure with preserved left ventricle ejection fraction and AF – related symptoms itself.
Downloads
References
Batul S, Gopinathannair R. Atrial Fibrillation in Heart Failure: a Therapeutic Challenge of Our Times. Korean Circulation Journal. 2017; 47 (5): 644–662. https://doi.org/10.4070/kcj.2017.0040
Park J, Lee J, Yang P, Kim T, Shin E, Park J, Uhm J, Joung B, Lee M and Pak H (2017). Good responders to catheter ablation for long-standing persistent atrial fibrillation: Clinical and genetic characteristics. Journal of Cardiology, 69 (3), pp. 584–590. https://doi.org/10.1016/j.jjcc.2016.04.017
Shah S, Moosa P, Fatima M, Ochani R, Shahnawaz W, Jangda M et al. Atrial fibrillation and heart failure- results of the CASTLE-AF trial. Journal of Community Hospital Internal Medicine Perspectives. 2018; 8 (4): 208–210. https://doi.org/10.1080/20009666.2018.1495979
Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2016; 37 (27): 2129–2200. https://doi.org/10.1093/eurheartj/ehw128
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomström-Lundqvist C et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2020. https://doi.org/10.1093/eurheartj/ehaa612
Lang R, Badano L, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography. 2015; 28 (1): 1–39.e14. https://doi.org/10.1016/j.echo.2014.10.003
Marrouche N, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L et al. Catheter Ablation for Atrial Fibrillation with Heart Failure. New England Journal of Medicine. 2018; 378 (5): 417–427. https://doi.org/10.1056/nejmoa1707855
Mont L, Bisbal F, Hernández-Madrid A, Pérez-Castellano N, Viñolas X, Arenal A et al. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). European Heart Journal. 2013; 35 (8): 501–507. https://doi.org/10.1093/eurheartj/eht457
Cha Y, Wokhlu A, Asirvatham S, Shen W, Friedman P, Munger T et al. Success of Ablation for Atrial Fibrillation in Isolated Left Ventricular Diastolic Dysfunction. Circulation: Arrhythmia and Electrophysiology. 2011; 4 (5): 724–732. https://doi.org/10.1161/circep.110.960690
Ichijo S, Miyazaki S, Kusa S, Nakamura H, Hachiya H, Kajiyama T et al. Impact of catheter ablation of atrial fibrillation on long-term clinical outcomes in patients with heart failure. Journal of Cardiology. 2018; 72 (3): 240–246. https://doi.org/10.1016/j.jjcc.2018.02.012
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
